Press "Enter" to skip to content

Salsanis Analytics

What is lecanemab, the newly approved Alzheimer’s drug? Can it really slow down dementia

Dementia is a condition that results in progressive memory or thinking problems. It’s now the most common cause of death in Australia. There are many different causes of dementia, but Alzheimer’s disease accounts for about 60%80% of all cases. Last week, Australia’s Therapeutic Goods Administration (TGA) approved a new drug for early Alzheimer’s diseases: lecanemab, [.] The post What is lecanemab, the newly approved Alzheimer’s drug? Can it really slow down dementia appeared first on Knowridge Science Report.

EXCLUSIVE: Meghan Markle ‘Still Feeling the Sting’ Of Martha Stewart’s Brutal Takedown of Wannabe Lifestyle Guru Duchess

Meghan Markle is still feeling the sting of Martha Stewart’s takedown of her lifestyle dreams.

IFC, ADB poised to pour $245M into Maynilad IPO

MANILA, Philippines – Two of the world’s major multilateral institutions may come in as cornerstone investors for the initial public offering (IPO) of Maynilad Water Services Inc. next month, chipping in as much as $245 million combined. In its latest preliminary prospectus, Maynilad said International Finance Corp. (IFC), the private sector arm of the World